CTSB and neoplasm: Likewise, this derivative showed inhibition of cathepsin B activity in tumour cells at concentrations of 1.52 ± 0.13 nM (ACHN cells) and 1.76 ± 0.24 nM (Hepa-1c1c7 cells).